Chemists seek new methods of drug design
Chemical & Engineering News · 1970
CHICAGO "In one's gloomier moments one wonders whether there are enough combinations left in organic chemistry to come up with novel drug molecules," muses Dr. John H. Biel. "But that is like asking how much more new music can be compose from a handful of basic notes." The head of Abbott Laboratories' general pharmacology department made the observation during a twoday symposium dealing with the science of drug discovery, which was sponsored by the Division of Medicinal Chemistry. All told, 16 experts whose professional careers are intimately bound to the pharmaceutical scene presented their views on topics that ranged from the physicochemical approaches to drug design to the economics of innovation in drug discovery and development, from the impact of basic biomedical research on drug discovery to the role of the National Institutes of Health in health research. Plans are under way to publish the entire proceedings of the symposium as a monograph in ...